ARJ
Arch Chemicals, Inc.NYSE
ARJ is defunct.
  • Jul. 19, 2011, 10:09 AM
    The SEC has filed an insider trading lawsuit accusing three Swiss entities of making millions of dollars on suspected insider trading before and after Arch Chemicals (ARJ) agreed to be bought by Switzerland’s Lonza Group (LZAGY.PK) for $1.2B earlier this month.
    | Jul. 19, 2011, 10:09 AM
  • Jul. 11, 2011, 9:05 AM

    Premarket gainers: ARJ +11%. AIS +8%. PSTI +6%. MITI +4%. SIRI +3%.
    Losers: ING -7%. NBG -6%. BBVA -6%. STD -5%. IRE -5%. TEF -5%. TEF -5%. RENN -5%. E -5%. BCS -4%. DB -4%. LYG -4%. TS -4%. ALU -4%. CTIC -4%. NOK -4%. BUD -4%. TOT -4%. TSEM -4%. SI -3%. FRO -3%. CPST -3%. MT -3%. SDRL -3%. RCL -3%. CS -3%. STO -3%. AMD -3%. UN -3%. SINA -3%.

    | Jul. 11, 2011, 9:05 AM
  • Jul. 11, 2011, 4:19 AM

    Lonza (LZAGF.PK) agrees to buy Arch Chemicals (ARJ) for $1.4B, or $47.20/share, a 37% premium to Arch's average closing price over the last 30 days. The deal, announced this morning, creates the world's largest microbial-control business, but regulators may be more concerned by the 11% spike in Arch's shares on Friday on unusually high volume.

    | Jul. 11, 2011, 4:19 AM
  • Jul. 8, 2011, 2:32 PM
    Arch Chemicals (ARJ), a maker of chemicals for water sanitation purposes, is up 9.1 % today, putting its shares within striking distance of their 52-week high. Though trading volume is already more than 4x Arch's 3-month average, no news has hit the wires explaining the move. Arch's shares also rose on unusually high volume on Wednesday.
    | Jul. 8, 2011, 2:32 PM